Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 119

1.
2.

Prediction of response to haloperidol in schizophrenia: neuroendocrine, neuromorphological and clinical variables.

Mauri MC, Vita A, Giobbio GM, Ferrara A, Dieci M, Bitetto A, Altamura AC.

Int Clin Psychopharmacol. 1994 Spring;9(1):3-7.

PMID:
8195579
3.

Subjective response to neuroleptics in schizophrenia.

Awad AG.

Schizophr Bull. 1993;19(3):609-18.

PMID:
7901897
4.

Rating of medication influences (ROMI) scale in schizophrenia.

Weiden P, Rapkin B, Mott T, Zygmunt A, Goldman D, Horvitz-Lennon M, Frances A.

Schizophr Bull. 1994;20(2):297-310.

PMID:
7916162
5.

[Comparison of 2 depression scales and their relationship with negative and akinetic symptoms in stabilized schizophrenic patients].

Langlois-Thery S, Dollfus S, Lesieur P, Petit M.

Encephale. 1994 Sep-Oct;20(5):487-93. French.

PMID:
7828511
6.

Predicting outcome of neuroleptic treatment on the basis of subjective response and early clinical improvement.

Bartkó G, Herczeg I, Békésy M.

J Clin Psychiatry. 1987 Sep;48(9):363-5.

PMID:
3624207
7.

Early subjective response and prediction of outcome to neuroleptic drug therapy in schizophrenia.

Hogan TP, Awad AG, Eastwood MR.

Can J Psychiatry. 1985 Jun;30(4):246-8.

PMID:
2861887
8.

Subjective response as a predictor of outcome in pharmacotherapy: the consumer has a point.

Van Putten T, May PR.

Arch Gen Psychiatry. 1978 Apr;35(4):477-80.

PMID:
727898
9.

Subjective response to antipsychotic drugs: failure to replicate predictions of outcome.

Ayers T, Liberman RP, Wallace CJ.

J Clin Psychopharmacol. 1984 Apr;4(2):89-93.

PMID:
6707245
10.

The measurement of subjective experience in schizophrenia: the Subjective Deficit Syndrome Scale.

Jaeger J, Bitter I, Czobor P, Volavka J.

Compr Psychiatry. 1990 May-Jun;31(3):216-26.

PMID:
2340716
11.

[Value of neuroleptic therapy in the self assessment of schizophrenic patients].

Heim M.

Psychiatr Neurol Med Psychol (Leipz). 1987 Aug;39(8):487-91. German.

PMID:
3685210
12.

Early treatment events and prediction of response to neuroleptics in schizophrenia.

Awad AG, Hogan TP.

Prog Neuropsychopharmacol Biol Psychiatry. 1985;9(5-6):585-8.

PMID:
2868492
13.

The effects of risperidone on the five dimensions of schizophrenia derived by factor analysis: combined results of the North American trials.

Marder SR, Davis JM, Chouinard G.

J Clin Psychiatry. 1997 Dec;58(12):538-46. Erratum in: J Clin Psychiatry 1998 Apr;59(4):200.

PMID:
9448657
14.

Prediction of drug responses in schizophrenia: a method using a test dose of chlorpromazine.

Minami H, Nakahara T, Miyahara A, Nakane Y.

Psychiatry Clin Neurosci. 1997 Aug;51(4):217-22.

15.

Antidepressants in 'depressed' schizophrenic inpatients. A controlled trial.

Kramer MS, Vogel WH, DiJohnson C, Dewey DA, Sheves P, Cavicchia S, Little P, Schmidt R, Kimes I.

Arch Gen Psychiatry. 1989 Oct;46(10):922-8.

PMID:
2679483
16.

Subjective response to neuroleptics: the effect of a questionnaire about neuroleptic side effects.

Taira M, Hashimoto T, Takamatsu T, Maeda K.

Prog Neuropsychopharmacol Biol Psychiatry. 2006 Aug 30;30(6):1139-42. Epub 2006 Jun 12.

PMID:
16765499
17.

Empirical evaluation of the factorial structure of clinical symptoms in schizophrenia: effects of typical neuroleptics on the brief psychiatric rating scale.

Harvey PD, Davidson M, White L, Keefe RS, Hirschowitz J, Mohs RC, Davis KL.

Biol Psychiatry. 1996 Oct 15;40(8):755-60.

PMID:
8894068
19.

Correlations between akathisia and residual psychopathology: a by-product of neuroleptic-induced dysphoria.

Newcomer JW, Miller LS, Faustman WO, Wetzel MW, Vogler GP, Csernansky JG.

Br J Psychiatry. 1994 Jun;164(6):834-8.

PMID:
7952993
20.

Supplemental Content

Support Center